Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Desloratadine 5 mg tablets versus Aerius 5 mg tablets in healthy Thai volunteers under fasting condition
TCTR20240427007Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and chronic idiopathic urticaria (CIU) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on TCTR20240427007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240427007.